Physician profile
Belinda W Dutton
NPI 1316058902
$9,423.07
in general payments reported to CMS, 2019-2025
38 companies · $1,375 in 2025
The $1,375 reported for 2025 was more than what 86% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,484 · 2022: $2,159 · 2023: $1,746 · 2024: $1,659 · 2025: $1,375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,780.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,581.82 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,421.87 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $960.20 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $928.14 | 2021-2025 | |
| Lilly USA, LLC | $927.62 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Amgen INC. | $360.94 | 2021-2025 | Evenity, Prolia, Otezla |
| Glaxosmithkline, LLC. | $355.45 | 2021-2025 | Trelegy Ellipta |
| Amarin Pharma, INC. | $296.05 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $256.26 | 2021-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $240.88 | 2021-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $224.37 | 2021-2025 | |
| Exact Sciences Corporation | $187.07 | 2023-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $152.41 | 2023-2025 | Gemtesa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $145.31 | 2021-2023 | Xifaxan |
| Radius Health, INC. | $139.79 | 2022-2024 | Tymlos |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Belinda Dutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.